Head-to-head · WeighScore
Tablet Health vs Trinity Meds
The verdict
Trinity Meds takes it — 61.2/100 to 47.6/100.
Trinity Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Trinity Meds is a telehealth weight-loss program aimed at military women, spouses and veterans, offering compounded GLP-1 medication on an all-inclusive flat monthly rate: semaglutide at $149/month and…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Tablet Health | Trinity Meds |
|---|---|---|
| WeighScore | 47.6/100 | 61.2/100 |
| Grade | C | C |
| Scorecard rank | #495 | #300 |
| Semaglutide | Not disclosed | $149/mo (compounded) |
| Tirzepatide | Not disclosed | $199/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #495 · C
Strengths
- LegitScript Certified
- Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
- Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
- Mid-tier pricing starting $179–$299/mo across all four product variants
- No commitment — cancel anytime
Where it loses points
- States served not published — you must complete the intake quiz to learn eligibility
- No founder, CEO, medical director, or pharmacist-in-charge named anywhere
- No BBB profile found
- Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Graded #300 · C
Strengths
- All-inclusive flat pricing — $149/month semaglutide, same price at every dose, no hidden fees
- Multi-month plans cut the cost further (semaglutide to $129/month, tirzepatide to $149/month)
- No insurance required, FSA eligible, with free shipping to your door
- Named operating entity (Trinity Meds Inc) and US-licensed clinicians via CareValidate Health
Where it loses points
- Doesn't publish the states it serves — you only learn eligibility after starting the assessment
- Pharmacy partners are described as 'multiple USA certified pharmacies' but none are named
- No terms-of-service page is posted (only a privacy policy)
- Compounded semaglutide and tirzepatide only — no brand-name or oral options
- Military framing is marketing; the program and pricing are open to anyone who qualifies
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.